QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
CVE:QPT

Quest PharmaTech (QPT) Stock Price, News & Analysis

C$0.03
-0.01 (-14.29%)
(As of 05:13 PM ET)
Today's Range
C$0.03
C$0.03
50-Day Range
C$0.02
C$0.04
52-Week Range
C$0.02
C$0.11
Volume
1,000 shs
Average Volume
50,651 shs
Market Capitalization
C$5.07 million
P/E Ratio
N/A
Dividend Yield
6.15%
Price Target
N/A
QPT stock logo

About Quest PharmaTech Stock (CVE:QPT)

Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.

QPT Stock Price History

QPT Stock News Headlines

Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Quest PharmaTech Inc. (QPT.V)
Quest Receives Cash Dividend Payment from OncoQuest
Best Meta Quest 2 Accessories for 2024
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Closing Bell: Quest Pharmatech Inc up on Thursday (QPT)
Closing Bell: Quest Pharmatech Inc flat on Thursday (QPT)
Closing Bell: Quest Pharmatech Inc down on Tuesday (QPT)
Meta Quest Promo Codes
Closing Bell: Quest Pharmatech Inc up on Tuesday (QPT)
QPT.V - Quest PharmaTech Inc.
Closing Bell: Quest Pharmatech Inc flat on Monday (QPT)
Quest PharmaTech Provides Product Development Update
Closing Bell: Quest Pharmatech Inc flat on Friday (QPT)
Closing Bell: Quest Pharmatech Inc down on Monday (QPT)
QPT.V - | Stock Price & Latest News | Reuters
See More Headlines
Receive QPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quest PharmaTech and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/16/2024
Next Earnings (Estimated)
5/29/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

Net Income
C$-22,260,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$38,871.00
Cash Flow
C$0.00 per share
Book Value
C$0.39 per share

Miscellaneous

Free Float
N/A
Market Cap
C$5.07 million
Optionable
Not Optionable
Beta
0.29
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Dr. Ragupathy Madiyalakan Ph.D.
    CEO & Director
  • Mr. Pierre Vermette C.A.
    CPA, Chief Financial Officer
  • Mr. Roger Andrews
    Head of Investor Relations & Corporate Communications
  • Mr. Douglas C. Bachman (Age 70)
    Vice President of Corporate Development
    Comp: $37.94k
  • Mr. Thomas Woo
    Vice President of Product Development

QPT Stock Analysis - Frequently Asked Questions

How have QPT shares performed in 2024?

Quest PharmaTech's stock was trading at C$0.06 at the start of the year. Since then, QPT stock has decreased by 45.5% and is now trading at C$0.03.
View the best growth stocks for 2024 here
.

When is Quest PharmaTech's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 29th 2024.
View our QPT earnings forecast
.

What other stocks do shareholders of Quest PharmaTech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Quest PharmaTech investors own include Indiva (NDVA), CME Group (CME) and

How do I buy shares of Quest PharmaTech?

Shares of QPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:QPT) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners